DESCRIPTION KLOW Blend Research Use Only KLOW Blend is a multi-peptide lyophilized research reference standard for in-vitro receptor binding assays, combination selectivity profiling, and structural characterization
A systematic review indicated that patients treated with GLP-1RAs had a significantly lower risk of incident HCC compared to those receiving other antidiabetic medications, such as insulin and sulfonylureas (Sha et al., 2024)
A new study published in JAMA Psychiatry looked at whether taking semaglutide reduced alcohol consumption and craving in adults with alcohol use disorder (AUD)
Quinet, A., Carvajal-Maldonado, D., Lemacon, D
Follow me for more GLP-1 friendly finds
A Liraglutide Injection Superimposing a Starvation Acidosis: a Case Report